Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RNAC | Cartesian Therapeutics, Inc. | President and CEO, Director | $3.44M | -$290K | -7.78% | Jan 3, 2025 |
SURF | Surface Oncology, Inc. | Director | Jun 28, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|